Lang Matthew (CIK 1712069) reported 3 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-04-23). Recent activity: Buy GPCR (184,614 shares), Sell MTSR (12,500 shares), Buy LYEL (112,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Structure Therapeutics Inc. (GPCR) | COO & GC | Buy | 184,614 | $0 |
| 2025-11-13 | Metsera, Inc. (MTSR) | CHIEF LEGAL OFFICER | Sell | 12,500 | $0 |
| 2025-02-26 | Lyell Immunopharma, Inc. (LYEL) | Chief Business Officer | Buy | 112,500 | $0 |
Source: SEC Form 4 filings · as of 2026-04-23